Verena Habermaass

Dr. Verena Habermaass

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2023 in Animals
Verified
Journal Article
Open access
PDF file
VHVerena Habermaass
Verena Habermaass
DODaniela Olivero
Daniela Olivero
Eleonora GoriEleonora Gori
Eleonora Gori
CMChiara Mariti
Chiara Mariti
ELErika Longhi
Erika Longhi
Veronica MarchettiVeronica Marchetti
Veronica Marchetti
The gut–liver axis represents a current topic in human medicine. Extensive research investigates the gut microbiome (GM) modifications in relation to various kinds of chronic hepatobiliary diseases (CHD), with many mechanisms and therapeutical implications recognized. Those aspects in veterinary medicine are still quite unexplored. The aim of the present study was to evaluate GM in dogs diagnosed with CD. Comparison among CHD dogs were made considering some clinical and biochemical variables (lipemia and alanine–aminotransferase activities), presence of cholestasis or endocrine disorders, diet). Sixty-five dogs were prospectively enrolled with clinical and hematobiochemical evaluation and 16S-RNA GM sequencing assessed. Dogs that received antibiotics and/or pre/pro/symbiotics administration were excluded. Deeper GM alteration was observed between dogs with or without ultrasonographic and biochemical cholestatic CHD. Cholestasis was associated with a decrease in several bacterial taxa, including Clostridium hiranonis, Fusobacterium, Megamonas, Ruminococcus faecis, Turicibacter, and higher levels of Escherichia/Shigella and Serratia. Thus, the alteration in bile flow and composition, typical of cholestasis, may directly affect the local intestinal microbial environment. For the management of dogs with CHD and especially cholestatic CHD, clinicians should be aware that gut–liver interaction may lead to dysbiosis.

22 October 2024 in Animals
Verified
Journal Article
Open access
PDF file
VHVerena Habermaass
Verena Habermaass
FBFrancesco Bartoli
Francesco Bartoli
Eleonora GoriEleonora Gori
Eleonora Gori
Rebecca DiniRebecca Dini
Rebecca Dini
ACAurora Cogozzo
Aurora Cogozzo
Veronica MarchettiVeronica Marchetti
Veronica Marchetti
The concentrations of fecal and serum bile acids (BAs) are known to be altered in human patients with chronic liver diseases (CLDs), especially those with biliary tract involvement (BTD). Scarce literature is available regarding fecal BA modifications during canine CLDs. This study aimed to evaluate fecal BAs in canine CLDs according to different clinical and clinicopathological variables. Forty-six dogs were enrolled. Canine feces were analyzed by HPLC. Cholic Acid (CA), Chenodeoxycholic Acid (CDCA), Ursodeoxycholic Acid (UDCA), Deoxycholic Acid (DCA), and Lithocholic Acid (LCA) were measured, and primary BAs (CA + CDCA), secondary BAs (UDCA + DCA + LCA), and the primary/secondary (P/S) ratio were calculated. Primary BAs (p < 0.0001), CA (p = 0.0003), CDCA (p = 0.003), the P/S ratio (p = 0.002), and total BAs (p = 0.005) were significatively higher in BTD dogs (n = 18) compared to in non-BTD dogs (n = 28). Fecal secondary BAs did not statistically differ between BTD and non-BTD dogs. Gastrointestinal clinical signs (p = 0.028) and diarrhea (p = 0.03) were significantly more prevalent in BTD dogs compared to in non-BTD dogs, supporting the hypothesis of some pathological mechanisms assimilable to bile acid diarrhea (BAD). Our results could reflect imbalances of the fecal BA metabolism in dogs with CLDs. Further studies involving gut microbiome and metabolomic assessment are needed to better understand the possible clinical implications of BA metabolism disruption and their potential role in canine CLDs.

20 June 2022 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
ILIlaria Lippi
Ilaria Lippi
VHVerena Habermaass
Verena Habermaass
Eleonora GoriEleonora Gori
Eleonora Gori
VEValentina Virginia Ebani
Valentina Virginia Ebani
alessio pierinialessio pierini
alessio pierini
Veronica MarchettiVeronica Marchetti
Veronica Marchetti
The diagnosis of urinary tract infections (UTIs) requires a concomitant evaluation of clinical signs and urine culture, which is of fundamental to start an appropriate antibiotic treatment. Several factors, such as subclinical bacteriuria or pre-analytical errors, may make the interpretation of urine culture difficult. The aim of the study was to evaluate the association between the finding of neutrophils and bacteria in unstained and stained canine urine sediment and the presence of clinical signs and positive urine culture. Urine samples from 35 dogs with clinical signs of UTI and 55 asymptomatic dogs with risk factors for UTI were prospectively collected by cystocentesis, divided into three aliquots, and submitted for: (1) physical and chemical Dipstick analysis and unstained urinary sediment (casts, crystals, bacteria, leucocytes, cells, parasites); (2) stained urinary sediment (extra/intracellular bacteria, degenerated and non-degenerated neutrophils); (3) qualitative and quantitative urine culture and antimicrobial sensitivity-test. The association between unstained and stained findings of urinary sediment and urine culture was tested. Sensibility, specificity, and positive/negative predictive values in diagnosing positive urine cultures of bacteria at unstained and stained evaluation were compared. Both wet-mount bacteriuria and the cytological presence of intracellular and extracellular bacteria, neutrophils, and degenerated neutrophils were successively associated with positive urine culture (p < 0.001). The presence of intracellular bacteria was the only independent predictor of positive urine culture. Total bacterial count did not differ significantly between symptomatic and asymptomatic dogs. Detection of extracellular and intracellular bacteriuria at stained urinary sediment significantly improved the sensibility of predicting positive urine culture. Cytologic evaluation of urinary sediment may be helpful in detecting signs of active inflammation, thus enhancing the clinical relevance of a positive urine culture.

2 March 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VHVerena Habermaass
Verena Habermaass
YTYuki Takami
Yuki Takami
TITakeshi Izawa
Takeshi Izawa
FAFrancesca Abramo
Francesca Abramo
CBCorrado Biolatti
Corrado Biolatti
Veronica MarchettiVeronica Marchetti
Veronica Marchetti
Chronic liver diseases (CLDs) in dogs are progressive conditions that often lead to liver failure. Metabolic dysfunctions such as cholestasis, obesity, hyperlipidemia, and endocrine disorders play a key role in human liver diseases like MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease) and MASH (Metabolic Dysfunction Associated Steatohepatitis), but their significance in canine CLDs is poorly understood. This study aims to evaluate the association between hepatic lipid accumulation and inflammation or fibrosis in canine CLDs and its potential association with metabolic dysfunctions. Sixteen client-owned dogs with CLDs were assessed for clinical data, histological features, and liver immunohistochemistry (IHC). Histological and IHC markers of inflammation (Iba-1, iNOS, NF-κB), fibrosis (CD206, α-SMA, Sirius Red), and lipid accumulation (adipophilin) were assessed to identify correlations with clinical conditions. The applied markers showed effectiveness in their use on canine liver tissue. Adipophilin-marked lipid accumulation correlated positively with inflammatory markers, indicating a link between steatosis and inflammation. Metabolic dysfunctions were linked to hepatic lipid accumulation and inflammation. These findings show a potential alignment of canine CLDs with human MASLD/MASH, where lipid-induced inflammation drives disease progression. IHC markers could effectively assess these processes, suggesting potential for guiding diagnostics and therapies, though further research is needed to clarify clinical associations.

25 August 2022 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VHVerena Habermaass
Verena Habermaass
Eleonora GoriEleonora Gori
Eleonora Gori
FAFrancesca Abramo
Francesca Abramo
FBFrancesco Bartoli
Francesco Bartoli
alessio pierinialessio pierini
alessio pierini
Veronica MarchettiVeronica Marchetti
Veronica Marchetti
In humans, chronic liver disease may cause alterations in amino acids (AAs) metabolism, with serum branched-chain AAs (BCAAs) decreasing and aromatic AAs (AAAs) increasing. A reduced Fischer ratio (BCAAs/AAAs) has been found to be associated with hepatic fibrosis and is useful for assessing prognosis in human patients. In veterinary medicine, few studies have been performed, and in contrast to human patients, dogs with different kinds of hepatopathy tend to show both increased AAAs and BCAAs. In dogs, the association between histological scores and serum AAs has not been previously investigated. The aim of this study was to evaluate serum AAs in dogs with chronic hepatitis (CH) compared with a healthy control group (C) and, among CH dogs, in relation to their histological fibrosis and necroinflammatory activity scores. Leftover serum samples of 16 dogs with histological CH and 25 healthy dogs were employed. Serum AAs were measured by high performance liquid chromatography. Proline and the AAAs phenylalaine and tyrosine progressively increased with the histological severity. In contrast, cysteine, tryptophan and BCAA isoleucine progressively reduced. Lysine and the BCAAs leucine and valine showed a non-linear trend with the histological findings. The BCAAs/AAAs ratio was significatively reduced if higher grades of liver fibrosis were present.

27 June 2025 in Animals
Verified
Journal Article
Open access
PDF file
CMChiara Mariti
Chiara Mariti
GRGiulia Russo
Giulia Russo
CMChiara Mazzoni
Chiara Mazzoni
CBCarmen Borrelli
Carmen Borrelli
Eleonora GoriEleonora Gori
Eleonora Gori
Veronica MarchettiVeronica Marchetti
Veronica Marchetti
Considering the controversial findings in the existing literature, this study aimed to deepen the knowledge about Hair Cortisol Concentration (HCC) in dogs by evaluating the influence on HCC of some factors related to dogs and guardians. Hair was collected from two groups: 128 Healthy Dogs (HD) and 25 dogs with a primary Chronic Gastroenteric Disease (CGD). Guardians of HD filled in a questionnaire, including dogs and respondents’ demographic information, and the perceived welfare and behaviour of the dog. HCC were measured with an enzyme immunoassay kit. A Wilcoxon rank-sum test was conducted to compare HCC in HD and CGD. For HD, a multiple linear regression and an ordinary logistic regression were performed with the dependent variable being HCC and the independent variables being dog and guardian characteristics and the questionnaire evaluations. HCC was statistically lower in CGD (medians: 4.79 versus 6.41 pg cortisol/mg hair; W = 961, p < 0.001). A positive association between HCC and guardian’s age was found (β: 0.012; t-value = 3.205; p < 0.01). Previous literature has shown that several factors can affect HCC in dogs; however, given the controversial results, a large sample and a multiparametric analysis, as in this study, can advance knowledge and highlight newly investigated factors. This study revealed the importance of also considering factors related to the guardian and the possibility that multiple factors interact and collectively influence HCC.